HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹1,481 Cr | ₹1,590 Cr | ₹1,621 Cr | ₹1,446 Cr | ₹1,305 Cr |
What is the latest Total Non-Current Assets ratio of HIKAL ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2026 | ₹1,481 Cr |
| Mar2025 | ₹1,590 Cr |
| Mar2024 | ₹1,621 Cr |
| Mar2023 | ₹1,446 Cr |
| Mar2022 | ₹1,305 Cr |
How is Total Non-Current Assets of HIKAL Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,481 Cr | -6.81 | |
| Mar2025 | ₹1,590 Cr | -1.93 | |
| Mar2024 | ₹1,621 Cr | 12.05 | |
| Mar2023 | ₹1,446 Cr | 10.86 | |
| Mar2022 | ₹1,305 Cr | - | |
Compare Total Non-Current Assets of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,735.4 Cr | -0.3% | 5.1% | -3.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | 1.2% | 9.1% | 6.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹296,741.0 Cr | -2.7% | 22.2% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1% | 2% | 20.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,771.0 Cr | 1.5% | 13% | 12.1% | Stock Analytics | |
| CIPLA | ₹114,397.0 Cr | 1.7% | 7.8% | -7.3% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -0.3% |
5.1% |
-3.3% |
| SENSEX | 1.4% |
12.4% |
-1.7% |
You may also like the below Video Courses